Clinical trial
Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease…
NCT00053599 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00053599 |
|---|---|
| Title | Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study |
| Official title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin to Slow the Progression of Alzheimer's Disease |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Alzheimer's Disease Cooperative Study (ADCS) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Simvastatin |
| Enrollment | 400 |
| Start date | Dec 1, 2002 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Feb 4, 2003 |
| Last update posted | Jul 28, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: